Amanita Muscaria: The Legal Mushroom Trending in Asheville Retail.

A new category of “legal psychedelics” is quietly growing in U.S. stores. Asheville, North Carolina, has become a visible hotspot for these products. Among them, Amanita muscaria stands out. This red-capped mushroom has a unique legal status, produces psychoactive effects, and is now common in hemp and wellness shops. 

As cannabis laws change and psilocybin stays restricted, Amanita muscaria is stepping into the spotlight. Regulators are only starting to pay attention.

What Is Amanita Muscaria?

Before exploring its retail growth, it helps to understand what makes this mushroom different.

Amanita muscaria, also known as the “fly agaric,” is a psychoactive mushroom. It features a bright red cap with white spots. Unlike psilocybin mushrooms, its effects come from muscimol and ibotenic acid, not psilocybin.

Click here to know more:

Amanita muscaria explained by Noah Seigel

Key Differences from Psilocybin Mushrooms

Amanita muscaria differs from traditional psychedelics in many key ways:

• Active compounds: It contains muscimol instead of psilocybin.

• Legal status: It is often unscheduled in the U.S.

• Effects: It produces sedative, dreamlike, and sometimes dissociative feelings rather than classic psychedelic visuals.

Because it falls outside many drug laws, Amanita products are frequently marketed as a “legal alternative” to psilocybin.

Why Asheville?

To understand the trend, we need to look at Asheville’s unique retail scene.

Asheville has long been known for its progressive culture, tourism, and strong hemp and wellness businesses. After the 2018 Farm Bill, hemp-derived products like CBD and Delta-8 THC helped create a thriving retail ecosystem across North Carolina.

A Retail Culture Built on Hemp Innovation

This environment has let shops experiment with new and legally gray products. These include:

• Functional mushrooms such as lion’s mane and reishi

• Hemp-derived cannabinoids

• Novel psychoactive items like Amanita gummies

Coverage of North Carolina markets often shows how regulatory gaps let new product categories appear before lawmakers can respond.

The Legal Loophole Driving Sales

Now we come to the key reason behind Amanita’s rise: legality.

Not Scheduled Like Psilocybin

In the United States, Amanita muscaria is generally not listed as a controlled substance, unlike psilocybin mushrooms.

This creates a legal gray area where

• Possession is typically legal

• Sale is often allowed (with restrictions depending on use)

• Regulation is minimal or unclear

But Not Fully Approved

However, legality does not mean approval or safety.

In December 2024, the U.S. Food and Drug Administration (FDA) issued a warning stating that Amanita muscaria and its compounds are not authorized for use in food and may pose health risks.

This creates a contradiction:

• Legal to sell in some forms

• Not approved as a food ingredient

That gap is exactly what retailers are currently exploiting.

Amanita Products in Asheville Shops

With the legal backdrop in mind, here’s what is actually being sold.

Retailers in Asheville and similar markets offer Amanita in several formats:

Common Product Types

• Gummies and chocolates

• Capsules and tinctures

• Dried mushroom products

• “Microdose” wellness blends

These products are often marketed with language similar to cannabis or psychedelics. Brands frequently highlight “chill” or “euphoria” effects. Many promote them as “legal trip” alternatives. This appeals to people who want psychoactive experiences without legal risks. They are also commonly labeled as “mushroom edibles.” This makes them feel familiar and approachable, especially for those already used to cannabis-infused products.

Some products even use candy-style packaging, which has raised regulatory concerns.

The Appeal: Why Consumers Are Buying

Understanding demand is just as important as understanding supply.

A Legal Psychedelic Alternative

Consumers choose Amanita for three main reasons:

• It delivers psychoactive effects without being illegal

• It is easy to buy in stores (no medical card needed)

• Online trends spark curiosity

Search interest in Amanita muscaria has grown sharply, driven by commercialization and online marketing.

Wellness and Experimentation

Another big driver is its connection to wellness culture:

• It is sold next to CBD and adaptogens

• It is positioned as a “natural” experience

• It is marketed for relaxation and a better mood

This mix of wellness products and psychoactive substances makes Amanita especially appealing in boutique shops like those in Asheville.

Click here to understand the appeal:

https://www.youtube.com/shorts/c9q0Ngdok5M

Risks and Public Health Concerns

Even though it is becoming more popular, Amanita muscaria has many safety risks that are still being studied. Because these products aren't strictly regulated, there isn't much oversight on how they are made or labeled, which can be dangerous for users.

• Unpredictable Effects: The experience can be very different for everyone. While some people feel relaxed, others might feel confused, sick to their stomach, or dizzy. These effects depend on the dose and how the mushroom was prepared. Without official rules, it’s hard to know exactly what to expect.

• FDA Warnings: The FDA has reported cases of people getting sick from these products. They have also warned that there isn't enough safety data to show these mushrooms are safe to eat.

• Confusing Labels: Some products may have misleading labels that make them seem safer than they actually are. Because of these risks, the FDA currently advises people to avoid any food or treats containing Amanita compounds.

Regulators Are Starting to Pay Attention

As Amanita products become more popular, they are catching the eye of government officials. This is a common pattern: when a new product sells quickly without many rules, regulators eventually step in to close the gaps.

• Following the Path of Delta-8: The rise of Amanita looks a lot like what happened with Delta-8 THC. Both started by using legal loopholes to stay on shelves with very little oversight. Eventually, many states passed their own bans or rules because federal laws were too slow to change.

• The "Policy Lag": This "gray market" exists because innovation moves much faster than the law. While these products are available now, they are currently in a temporary period of low regulation that likely won't last.

What Could Happen Next?

Based on how other products have been handled, here is what we might see soon:

• State Bans: Individual states may start banning Amanita products, especially when they are sold as candy or snacks.

• FDA Crackdowns: The FDA could start taking more action against companies that sell Amanita as "food" or "supplements" without proof that they are safe.

• New Federal Rules: The government might create a clear nationwide rule on how to classify and sell Amanita.

The FDA's recent warnings suggest that these changes are already starting to happen.

The Future of Amanita in Retail

Looking ahead, the Amanita market sits at a crossroads.

Short-Term Outlook

In the near term, expect:

• Continued growth in boutique and hemp shops

• Expansion of branded Amanita products

• Increased consumer awareness

Long-Term Uncertainty

However, long-term viability depends on regulation:

• Will it be treated like cannabis, supplements, or something else?

• Will safety standards be introduced?

• Will enforcement limit retail sales?

The answers will determine whether Amanita becomes a lasting category or just another short-lived loophole product.

Conclusion

The growth of Amanita muscaria in Asheville stores shows how quickly new markets can pop up in "legal gray areas." As more people become interested, health experts are growing more concerned about safety. Just as we saw with Delta-8, the future of these mushrooms will likely depend on how quickly lawmakers create new rules to balance personal freedom with public safety.